Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs D, Kasper LH, Lynch S, Parry G, Racke MK, Reder AT, Rose J, Wingerchuk DM, MacKenzie-Graham AJ, Arnold DL, Tseng CH, Elashoff R. Voskuhl RR, et al. Among authors: Bardens J. Lancet Neurol. 2016 Jan;15(1):35-46. doi: 10.1016/S1474-4422(15)00322-1. Epub 2015 Nov 29. Lancet Neurol. 2016. PMID: 26621682 Free article. Clinical Trial.
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.
Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. Ringman JM, et al. Among authors: Bardens J. Alzheimers Res Ther. 2012 Oct 29;4(5):43. doi: 10.1186/alzrt146. eCollection 2012. Alzheimers Res Ther. 2012. PMID: 23107780 Free PMC article.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.
Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study. Galasko DR, et al. Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85. Arch Neurol. 2012. PMID: 22431837 Free PMC article. Clinical Trial.
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ; Alzheimer Disease Cooperative Study. Aisen PS, et al. JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774. JAMA. 2008. PMID: 18854539 Free PMC article. Clinical Trial.
Developmental myopathy in the canine with type II muscle fiber hypotrophy.
Cardinet GH 3rd, Wallace LJ, Fedde MR, Guffy MM, Bardens JW. Cardinet GH 3rd, et al. Among authors: Bardens JW. Arch Neurol. 1969 Dec;21(6):620-30. doi: 10.1001/archneur.1969.00480180076007. Arch Neurol. 1969. PMID: 5355256 No abstract available.
New observations on the diagnosis and cause of hip dysplasia.
Bardens JW, Hardwick H. Bardens JW, et al. Vet Med Small Anim Clin. 1968 Mar;63(3):238-45. Vet Med Small Anim Clin. 1968. PMID: 5183841 No abstract available.
Glycogen storage disease in puppies.
Bardens JW. Bardens JW. Vet Med Small Anim Clin. 1966 Dec;61(12):1174-6. Vet Med Small Anim Clin. 1966. PMID: 5232754 No abstract available.
Feedback